Early Diagnosis of Alzheimer’s Disease with PET-CT Brain Scan (Vizamyl)
Alzheimer’s disease is a severe neurodegenerative disorder of the brain that causes a gradual decline in memory, thinking, and behavior.
Common symptoms include short-term memory loss, difficulty performing familiar daily tasks, confusion, and personality or behavioral changes.
What Causes Alzheimer’s Disease?
In a healthy brain, neurons (nerve cells) naturally die and renew at a steady rate as part of the aging process.
However, in neurodegenerative diseases like Alzheimer’s, this process accelerates abnormally. The rapid and progressive loss of neurons leads to deterioration of memory, cognitive functions, and daily performance.
One of the key causes of neuronal death is the accumulation of amyloid protein plaques in the brain. These deposits, sometimes combined with sugars and other substances, are considered a major risk factor for developing Alzheimer’s disease.
Importantly, amyloid buildup can begin 20–25 years before the first clinical symptoms appear.
Why Early Detection Matters
Early diagnosis of amyloid deposits in the brain enables physicians to take proactive measures — including lifestyle modifications, advanced preventive treatments, and participation in innovative therapeutic programs that aim to reduce amyloid levels and slow or prevent disease progression.
What Is a PET-CT Brain Scan?
A PET-CT scan is an advanced medical imaging test that combines two technologies CT scan and PET:
- CT (Computed Tomography):
provides detailed anatomical images of the brain.
- PET (Positron Emission Tomography): shows the functional and metabolic activity of brain tissues using small amounts of radioactive materials.
By combining these two imaging methods, PET-CT offers highly accurate information about both structure and function, helping doctors identify abnormal processes in the brain.
Vizamyl – Innovative Imaging for Amyloid Detection
Vizamyl is a special radiopharmaceutical agent that binds to amyloid plaques in the brain. When used in a PET-CT scan, it highlights areas where amyloid protein accumulates, allowing doctors to visually confirm the presence of amyloid deposits.
The PET-CT brain scan with Vizamyl is a safe, non-invasive procedure with no significant side effects or risks.
It is performed at a nuclear medicine imaging center in specialized hospitals.
The Importance of PET-CT Brain Scan for Alzheimer’s
Detecting amyloid deposits early — even before any symptoms appear — gives patients and doctors valuable time to take preventive actions.
Such early identification may allow for timely treatment adjustments, slowing disease progression, and preserving cognitive function for longer.
As medical research continues to advance, early detection with PET-CT (Vizamyl) is expected to become one of the most important tools in the fight against Alzheimer’s disease.
